Cargando…

Clinical significance of multiparametric MRI and PSA density as predictors of residual tumor (pT0) following radical prostatectomy for T1a-T1b (incidental) prostate cancer

PURPOSE: The aim of this study was to evaluate predictors of residual tumor and clinical prognosis in T1a-T1b (incidental) prostate cancer by analysis of specimens from men undergoing surgery for benign prostatic hyperplasia. MATERIALS AND METHODS: We retrospectively reviewed medical records of inci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Doo Yong, Goh, Hyeok Jun, Koh, Dong Hoon, Kim, Min Seok, Lee, Jong Soo, Jang, Won Sik, Choi, Young Deuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310270/ https://www.ncbi.nlm.nih.gov/pubmed/30592769 http://dx.doi.org/10.1371/journal.pone.0210037

Ejemplares similares

Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI
por: Chung, Doo Yong, et al.
Publicado: (2018)

Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy
por: Mazzucchelli, Roberta, et al.
Publicado: (2007)

Effect of prostate gland weight on the surgical and oncological outcomes of extraperitoneal robot-assisted radical prostatectomy
por: Kim, Min Seok, et al.
Publicado: (2019)

Predictive Factors and Oncologic Outcome of Downgrade to Pathologic Gleason Score 6–7 after Radical Prostatectomy in Patients with Biopsy Gleason Score 8–10
por: Chung, Doo Yong, et al.
Publicado: (2019)

Preoperative Clinical and Pathological Characteristics of pT0 Prostate Cancer in Radical Prostatectomy
por: Park, Junsoo, et al.
Publicado: (2010)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

The natural history of a delayed detectable PSA after radical prostatectomy
por: Szymaniak, Julie A., et al.
Publicado: (2023)

Multiparametric MRI in the PSA Screening Era
por: George, Arvin K., et al.
Publicado: (2014)

Urethral realignment with maximal urethral length and bladder neck preservation in robot-assisted radical prostatectomy: Urinary continence recovery
por: Heo, Ji Eun, et al.
Publicado: (2020)

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
por: Kang, Yong Jin, et al.
Publicado: (2017)

Nondetectable Prostate Carcinoma (pT0) after Radical Prostatectomy: A Narrative Review
por: Kalampokis, Nikolaos, et al.
Publicado: (2022)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Clinical Significance of Multiparametric Magnetic Resonance Imaging as a Preoperative Predictor of Oncologic Outcome in Very Low-Risk Prostate Cancer
por: Chung, Doo Yong, et al.
Publicado: (2019)

Endoscopic extraperitoneal radical prostatectomy after radical resection of pT1-pT2 rectal cancer: a report of thirty cases
por: Liu, Zhuo, et al.
Publicado: (2017)

Multiparametric MRI for Recurrent Prostate Cancer Post Radical Prostatectomy and Postradiation Therapy
por: Barchetti, Flavio, et al.
Publicado: (2014)

3.0-T multiparametric magnetic resonance imaging modifies the template of endoscopic, conventional radical prostatectomy in all cancer risk categories 
por: Kozikowski, Mieszko, et al.
Publicado: (2018)

Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy
por: Kim, Minsu, et al.
Publicado: (2022)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges
por: Lee, Hye Won, et al.
Publicado: (2015)

Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer
por: Park, Jae Won, et al.
Publicado: (2018)

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
por: Pye, Hayley, et al.
Publicado: (2021)

Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy
por: Wang, Nancy N, et al.
Publicado: (2018)

Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy
por: Joyce, Daniel D., et al.
Publicado: (2022)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort
por: Tanguturi, Shyam K., et al.
Publicado: (2014)

The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer
por: Joung, Jae Young, et al.
Publicado: (2015)

The long-term outcomes of radical prostatectomy for very high-risk prostate cancer pT3b-T4 N0-1 on definitive histopathology
por: Kliment, Jan, et al.
Publicado: (2017)

Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer
por: Kaushik, Dharam, et al.
Publicado: (2016)

Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy
por: Ho, Richard, et al.
Publicado: (2016)

Comparison of Biparametric and Multiparametric Prostate Magnetic Resonance Imaging in Predicting Oncologic Outcomes After Radical Prostatectomy
por: EFILOGLU, Ozgur, et al.
Publicado: (2022)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

(68)Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
por: von Eyben, Finn Edler, et al.
Publicado: (2021)

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

Incidental splenosis discovered during robotic assisted radical prostatectomy: A case report
por: McNamara, Molly A., et al.
Publicado: (2022)

Multiparametric MRI-based nomograms in predicting positive surgical margins of prostate cancer after laparoscopic radical prostatectomy
por: Meng, Shuang, et al.
Publicado: (2022)

Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy
por: Maeda, Yoko, et al.
Publicado: (2016)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8s7hgtnchc9thg8phj044ammi1